Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chengcheng Liu

Showing results (411-420 of 423) with videos related to

Pageof 43
Sort By:
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 23, 2020
No expenditure difference among patients with liver cancer at stage I<b>-</b>IV: Findings from a multicenter cross-sectional study in ChinaHaike Lei, Lin Lei, Jufang Shi, et al.
Pharmacogenetics and Genomics|June 20, 2017
Genetics of pleiotropic effects of dexamethasoneLaura B Ramsey, Stan Pounds, Cheng Cheng, et al.
Technology in Cancer Research & Treatment|February 2, 2023
A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: A Clinical Trial ProtocolJinjie He, Yue Liu, Chengcheng Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|December 10, 2019
Medical expenditures for colorectal cancer diagnosis and treatment: A 10-year high-level-hospital-based multicenter retrospective survey in China, 2002<b>-</b>2011Jufang Shi, Guoxiang Liu, Hong Wang, et al.
Blood|May 20, 2015
Genome-wide analysis links NFATC2 with asparaginase hypersensitivityChristian A Fernandez, Colton Smith, Wenjian Yang, et al.
Blood|November 22, 2015
Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemiaSeth E Karol, Leonard A Mattano, Wenjian Yang, et al.
Nature Cancer|May 27, 2022
Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancerChaping Cheng, Jinming Wang, Penghui Xu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2022
Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C)Hongda Chen, Jufang Shi, Ming Lu, et al.
Blood|June 28, 2014
HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergiesChristian A Fernandez, Colton Smith, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic LeukemiaChengcheng Liu, Wenjian Yang, Meenakshi Devidas, et al.
Pageof 43

Showing results (411-420 of 423) with videos related to

Sort By:
Pageof 43
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|September 23, 2020
No expenditure difference among patients with liver cancer at stage I<b>-</b>IV: Findings from a multicenter cross-sectional study in ChinaHaike Lei, Lin Lei, Jufang Shi, et al.
Pharmacogenetics and Genomics|June 20, 2017
Genetics of pleiotropic effects of dexamethasoneLaura B Ramsey, Stan Pounds, Cheng Cheng, et al.
Technology in Cancer Research & Treatment|February 2, 2023
A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for <i>RAS/BRAF</i> Wild-Type Metastatic Colorectal Cancer: A Clinical Trial ProtocolJinjie He, Yue Liu, Chengcheng Liu, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|December 10, 2019
Medical expenditures for colorectal cancer diagnosis and treatment: A 10-year high-level-hospital-based multicenter retrospective survey in China, 2002<b>-</b>2011Jufang Shi, Guoxiang Liu, Hong Wang, et al.
Blood|May 20, 2015
Genome-wide analysis links NFATC2 with asparaginase hypersensitivityChristian A Fernandez, Colton Smith, Wenjian Yang, et al.
Blood|November 22, 2015
Genetic risk factors for the development of osteonecrosis in children under age 10 treated for acute lymphoblastic leukemiaSeth E Karol, Leonard A Mattano, Wenjian Yang, et al.
Nature Cancer|May 27, 2022
Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancerChaping Cheng, Jinming Wang, Penghui Xu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 14, 2022
Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-Adapted Approach in a Colorectal Cancer Screening Trial (TARGET-C)Hongda Chen, Jufang Shi, Ming Lu, et al.
Blood|June 28, 2014
HLA-DRB1*07:01 is associated with a higher risk of asparaginase allergiesChristian A Fernandez, Colton Smith, Wenjian Yang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2016
Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic LeukemiaChengcheng Liu, Wenjian Yang, Meenakshi Devidas, et al.
Pageof 43